These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 22742869

  • 1. Efficacy of intravenous thrombolysis according to stroke subtypes: the Madrid Stroke Network data.
    Fuentes B, Martínez-Sánchez P, Alonso de Leciñana M, Egido J, Reig-Roselló G, Díaz-Otero F, Sánchez V, Simal P, Ximenez-Carrillo A, García-Pastor A, Ruiz-Ares G, García-García A, Masjuan J, Vivancos-Mora J, Gil-Nuñez A, Díez-Tejedor E, Madrid Stroke Network.
    Eur J Neurol; 2012 Dec; 19(12):1568-74. PubMed ID: 22742869
    [Abstract] [Full Text] [Related]

  • 2. Benefits of intravenous thrombolysis in acute ischemic stroke related to extra cranial internal carotid dissection. Dream or reality?
    Fuentes B, Masjuan J, Alonso de Leciñana M, Simal P, Egido J, Díaz-Otero F, Gil-Nuñez A, Martínez-Sánchez P, Díez-Tejedor E, Madrid Stroke Network.
    Int J Stroke; 2012 Jan; 7(1):7-13. PubMed ID: 22017881
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Kario K, Okuda S, Koga M, Minematsu K, Toyoda K.
    Cerebrovasc Dis; 2012 Jan; 34(2):140-6. PubMed ID: 22854333
    [Abstract] [Full Text] [Related]

  • 5. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
    Nesi M, Lucente G, Nencini P, Fancellu L, Inzitari D.
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
    [Abstract] [Full Text] [Related]

  • 6. Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry.
    Miyagi T, Koga M, Shiokawa Y, Nakagawara J, Hasegawa Y, Furui E, Kimura K, Kario K, Okuda S, Yamagami H, Okada Y, Nezu T, Maeda K, Endo K, Minematsu K, Toyoda K.
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1098-106. PubMed ID: 23063059
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of final infarct volumes in patients who received endovascular therapy or intravenous thrombolysis for acute intracranial large-vessel occlusions.
    Rangaraju S, Owada K, Noorian AR, Nogueira RG, Nahab F, Glenn BA, Belagaje SR, Anderson AM, Frankel MR, Gupta R.
    JAMA Neurol; 2013 Jul; 70(7):831-6. PubMed ID: 23699864
    [Abstract] [Full Text] [Related]

  • 10. Treatment with tPA predicts better outcome even if MCA occlusion persists.
    Kablau M, Alonso A, Hennerici MG, Fatar M.
    Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcomes after intravenous fibrinolysis in cryptogenic strokes with or without patent foramen ovale.
    Chang JJ, Chiem T, Alderazi YJ, Chapple K, Restrepo L.
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e492-9. PubMed ID: 23871701
    [Abstract] [Full Text] [Related]

  • 12. The efficacy of thrombolysis in lacunar stroke - evidence from the Austrian Stroke Unit Registry.
    Eggers CCJ, Bocksrucker C, Seyfang L, Austrian Stroke Unit Registry Collaborators.
    Eur J Neurol; 2017 Jun; 24(6):780-787. PubMed ID: 28449276
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome.
    Kellert L, Sykora M, Gumbinger C, Herrmann O, Ringleb PA.
    Cerebrovasc Dis; 2012 Jun; 33(2):135-40. PubMed ID: 22179586
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety assessment of alteplase in the treatment of stroke - gender differences.
    Lasek-Bal A, Puz P, Kazibutowska Z.
    Neurol Res; 2014 Sep; 36(9):851-6. PubMed ID: 24620981
    [Abstract] [Full Text] [Related]

  • 17. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
    Sobesky J, Frackowiak M, Zaro Weber O, Hahn M, Möller-Hartmann W, Rudolf J, Neveling M, Grond M, Schmulling S, Jacobs A, Heiss WD.
    Cerebrovasc Dis; 2007 Sep; 24(1):56-65. PubMed ID: 17519545
    [Abstract] [Full Text] [Related]

  • 18. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study.
    Wahlgren N, Ahmed N, Dávalos A, Hacke W, Millán M, Muir K, Roine RO, Toni D, Lees KR, SITS investigators.
    Lancet; 2008 Oct 11; 372(9646):1303-9. PubMed ID: 18790527
    [Abstract] [Full Text] [Related]

  • 19. Intravenous thrombolysis for patients with reverse magnetic resonance angiography and diffusion-weighted imaging mismatch: SAMURAI and NCVC rt-PA Registries.
    Sakamoto Y, Koga M, Kimura K, Nagatsuka K, Okuda S, Kario K, Hasegawa Y, Okada Y, Yamagami H, Furui E, Nakagawara J, Shiokawa Y, Okata T, Kobayashi J, Tanaka E, Minematsu K, Toyoda K.
    Eur J Neurol; 2014 Mar 11; 21(3):419-26. PubMed ID: 24261412
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.